[3] The R&D pipeline involves various phases that can broadly be grouped in 4 stages: discovery, pre-clinical, clinical trials and marketing (or post-approval).
The drug pipeline is an important indicator of the value and future prospects of a company.
However, these biotech companies may face failures, particularly in producing near-term products.
This can lead to the shutdown of the acquired companies, resulting in the loss of accumulated knowledge and expertise.
Assessing this risk and filtering out, as early as possible, compounds that may not eventually get approved is essential to the pharmaceutical industry and involves checking the effectiveness of drugs as well as the likelihood of toxic events (Adverse event prediction).